SNHG3 and B-cell chronic lymphocytic leukemia: Although DLEU2 and SNHG3 are not related to CML directly, related materials show that DLEU2 is closely related to CLL, which provides us with new insights into ceRNA-mediated CML therapeutic regulatory mechanisms and facilitates the diagnosis of biomarkers and CML therapeutic targets.